Long-term Safety Study for GSK573719 in Japanese
NCT01702363
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
131
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GSK573719
Sponsor
GlaxoSmithKline